The C-C chemokine receptor CCR5 in humans and rhesus macaques (Macaca mulatta) serves as the primary coreceptor for cellular entry by macrophagetropic strains of human immunodeficiency virus type 1 (HIV-1) and all reported strains of simian immunodeficiency virus (SIV) [1-6]. Humans homozygous for a 32 bp deletion allele of CCR5, resulting in a null phenotype, are highly resistant to infection by HIV-1 [7-9], prompting development of therapies and vaccines targeting CCR5. We now report a novel deletion allele of CCR5, with an allele frequency of 0.04, in sooty mangabey monkeys (Cercocebus torquatus atys), a natural host of SIV (SIVsmm) [10]. The mutant protein was not expressed at the cell surface and accordingly did not function as a viral coreceptor. Primary activated lymphocytes from mangabeys heterozygous for the deletion allele expressed significantly less CCR5 on the cell surface. Moreover, SIV seroprevalence and viremia were comparable among CCR5 heterozygotes and wild-type animals. Parallel evolution of CCR5-null alleles in humans and sooty mangabeys suggests that similar negative selection pressures have acted against CCR5, as would occur during epidemics of infectious agents that require CCR5 for pathogenesis. Sooty mangabeys bred to homozygosity for the deletion allele will be useful for experimental studies on the context-dependent role of CCR5 in host defense and microbial pathogenesis. 
Results and discussion
Two alleles of sooty mangabey CCR5 (smCCR5) were cloned by PCR using genomic DNA templates from six animals residing at the Yerkes Regional Primate Research Center. The wild-type smCCR5 allele (Genbank accession number AF079472) has 97.5% nucleotide sequence similarity to human CCR5 (huCCR5) [11] and 99.1% similarity to rhesus macaque CCR5 (rhCCR5) [6] . The second allele (smCCR5∆24; Genbank accession number AF079473) contains a 24 bp deletion corresponding to eight amino acids within the predicted fourth transmembrane segment. In addition to this deletion, the two smCCR5 alleles differed from one another at two sites representing a silent Leu236 mutation and a Ser180→Pro amino-acid substitution in the wild-type protein.
To evaluate both smCCR5 alleles for their capacity to mediate viral fusion and entry, we used a transient transfection/infection assay based on flow cytometric detection of intracellular SIV gag p27 as a marker of viral infection of cells [12] . SIVmac239, a CCR5-utilizing virus (R5 virus), established comparable levels of infection in COS-7 cells cotransfected with huCD4 and either huCCR5, rhCCR5 or wild-type smCCR5, but was unable to infect COS-7 cells SIV gag p27 expression after SIVmac239 challenge of COS-7 cells transiently transfected with CCR5 expression vectors. Infection studies were performed using a method previously described for HIV-1 infection studies [12] . Transiently transfected COS-7 cells were infected in triplicate with doses of 32,000 TCID 50 of a stock of SIVmac239 passaged once on CEM × 174 cells. SIV gag p27 expression detected by flow cytometry was used to identify cells that had been infected by SIVmac239 after gating on transfected CD4 + cells. Transfection efficiency for CD4 and CCR5 constructs was 10-20% in each experiment. NS, not significant. transfected with huCD4 alone (Figure 1 ). Similar experiments indicated that smCCR5 functioned as well as huCCR5 as a viral coreceptor for HIV-1 Ba-L , another R5 virus (data not shown). These experiments indicate conserved function of the wild-type sooty mangabey homologue of CCR5 as a viral receptor. In contrast, SIVmac239 did not infect COS-7 cells cotransfected with huCD4 and smCCR5∆24 significantly more than cells transfected with vector controls, indicating loss of smCCR5∆24 function as a viral coreceptor.
To explain why smCCR5∆24 fails as a viral coreceptor, we evaluated the cell-surface expression of deleted and wildtype alleles of CCR5 in transiently transfected COS-7 cells. CCR5 amplicons were cloned into the mammalian expression vector pcDNA3 (Invitrogen) with a signal sequence and the FLAG epitope (DYKDDDDK in the single-letter amino-acid code) fused to the amino terminus [13] to allow detection of intracellular translation if the protein failed to be expressed on the cell surface. Surface expression and total expression were visualized by immunofluorescence microscopy ( Figure 2 ) and quantitated by flow cytometry (Table 1) using an anti-FLAG monoclonal antibody (M2) before and after cell fixation and membrane permeabilization. Transfection with wildtype CCR5 plasmids produced high levels of CCR5 expression on the surface of viable cells, whereas surface expression of smCCR5∆24 was not detected. In contrast, staining of fixed and permeabilized smCCR5∆24-transfected cells revealed an abundance of the translated protein inside cells. This verified that the construct was translated but that the mutant protein failed to be transported to the cell surface. It is likely that the lack of cellsurface expression is due to the 24 bp deletion disrupting the fourth transmembrane segment. The mutant protein also differs from the wild type by a proline-to-serine substitution at position 180, but this is unlikely to affect expression because the serine codon is conserved in all reported primate CCR5 sequences.
The expression of CCR5 on primary sooty mangabey peripheral blood mononuclear cells (PBMCs) was evaluated by flow cytometry using an anti-human-CCR5 antibody that cross-reacted with smCCR5. Seven days after activation of PBMCs, surface expression (measured by mean channel fluorescence) was 2.4-fold higher in six smCCR5/smCCR5 mangabeys than in six smCCR5/smCCR5∆24 mangabeys ( Figure 3 ; p = 0.002). The decreased cell-surface expression of CCR5 in mangabeys heterozygous for the smCCR5∆24 allele indicates that the identified deletion is not due to a PCR artifact and that the smCCR5∆24 sequence does not represent a pseudogene. In addition, the expression of smCCR5 on PBMCs was similar in SIVsmm-infected and uninfected sooty mangabeys. An analogous decrease of CCR5 expression has been observed in humans heterozygous for the 32 bp deletion allele of CCR5 [14] and attributed to multimerization between the wild-type and the truncated gene products causing retention of CCR5 in the endoplasmic reticulum [15] .
To assess the frequency of the smCCR5∆24 allele, all sooty mangabeys residing at the Yerkes Regional Primate Research Center were genotyped using a PCR-based assay and genomic DNA extracted from PBMCs. Of 259 animals tested, 238 were homozygous wild type (smCCR5/smCCR5) and 21 were heterozygous (smCCR5/smCCR5∆24). No homozygous smCCR5∆24/smCCR5∆24 mangabeys were identified. Hence, the allele frequency for smCCR5∆24 at this particular primate center is estimated to be 0.04 (from 944 Current Biology, Vol 8 No 16
Figure 2
Surface and total expression of FLAG-tagged CCR5 transfected into COS-7 cells. Expression of FLAG-tagged smCCR5 and smCCR5∆24 was detected by staining cells with phycoerythrin (PE)-conjugated anti-FLAG antibodies (Kodak) and visualized by immunofluorescence microscopy at 400× using a Leitz Diaplan microscope and Rho Filter (450-490 bandpass excitation, 525 ± 20 bandpass emission). Surface expression was detected before permeabilization and total expression was detected after permeabilization (Fix and Perm Kit; Caltag) of cells transfected in parallel. Film exposure and processing was constant for all panels. Seroprevalence was comparable in heterozygous and wild-type sooty mangabeys (10/21 = 48% versus 22/38 = 58%, respectively). The level of viremia among seropositive mangabeys, measured using a quantitative competitive reverse transcription PCR assay [18] , was comparable among seven wild-type animals (mean 6.1 log 10 RNA copies/ml; range 5.2 to 6.7) relative to five heterozygous animals (mean 6.5 log 10 RNA copies/ml; range 5.6 to 7.0; p is not significant). Analogous comparisons of seroprevalent humans heterozygous for CCR5∆32 also revealed no difference in viremia, although a small decrease in viremia (mean ∆log 10 = -0.39) was detectable in heterozygous humans when duration of infection was known and controlled for in analysis [19] . Although too few heterozygous mangabeys are available to detect small differences in viremia, this analysis demonstrates that sooty mangabeys heterozygous for CCR5∆24 can be naturally infected with SIV and that SIV infection results in typical high level viremia [20] .
The significance of the smCCR5 deletion allele in SIVsmm-host interactions remains unclear. At present, resistance to SIVsmm infection among CCR5-null sooty mangabeys would not confer a substantial reproductive advantage because SIVsmm-infected sooty mangabeys do not have higher rates of mortality or morbidity [21] . It is possible that viruses ancestral to current SIVsmm variants were pathogenic upon introduction into mangabey populations and that polymorphisms of viral receptors which decreased susceptibility to infection or disease were selected. Interestingly, sooty mangabey CD4 is also polymorphic, with two alleles that differ by 4 amino acids including a tyrosine-to-isoleucine substitution in the complementarity determining region 2 (CDR2) [22] that is involved in env-CD4 interactions. Although mutant alleles of CD4 and CCR5 in sooty mangabeys are no longer essential for host tolerance of current SIVsmm infection, these host polymorphisms may persist as vestigial remnants of prior selection against wild-type alleles.
The parallel evolution of CCR5 null alleles, one in the natural host of SIVsmm and the other conferring high resistance to HIV-1 in humans, suggests that ancient epidemics of ancestral viruses may have been important in shaping primate genomes. The high incidence of endogenous retroviruses (1%) and RNA-derived DNA (5%) in the human genome suggests a role for retroviruses in shaping human evolution (reviewed by Lower et al. [23] CCR5 expression on sooty mangabey blood lymphocytes. PBMCs were activated with anti-simian-CD3 antibodies (BioSource), and recombinant human interleukin-2 (100 U/ml; Chiron) was added to the culture 2 days after activation. Lymphocytes were identified using flow cytometry by forward and side-scatter characteristics and were assayed by staining with PE-conjugated anti-CCR5 antibody (3A9) for expression of CCR5 on day 7 after activation. 
Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus

Materials and methods
Cloning and sequencing of mangabey CCR5
Full-length sooty mangabey CCR5 was amplified by PCR using primers that bind outside the open reading frame (ORF). Primers were (forward) 5′-TCGAAAGCTTCCCCGGGTGGAACAAGATG-3′ and (reverse) 5′-CTGAGGATCCGCCATGTGGCACAACTCT-3′, corresponding to the published human CCR5 sequence. The forward primer overlaps the start ATG and the reverse primer lies downstream of the presumed stop codon. The PCR reactions contained rTth DNA polymerase XL (2.5 units) in XL Buffer II (Perkin Elmer), Mn(OAc) 2 (2.25 mM), primers (0.4 mM each), dNTPs (0.2 mM) each in a 50 µl reaction volume. Thermocycling conditions were as follows: an initial 3 min denaturation step at 94°C followed by 45 cycles of 10 sec at 93°C, 15 sec at 45°C and 30 sec at 72°C, and a final extension step of 10 min at 72°C. Genomic DNA from sooty mangabey PBMCs was extracted from buffy coats using silica columns (Qiagen) and 0.1-0.5 µg was used as template DNA for all amplification reactions. Resulting products were TA-cloned into the pGEM-T vector (Promega), and the amino and carboxyl termini of multiple clones from several animals (including possible heterozygotes) were sequenced by d-rhodamine-labeled terminators and SP6 and T7 sequencing primers. The first and last 18 bp of the cloned ORFs were identical in sequences from all six mangabeys, including heterozygous smCCR5/smCCR5∆24 mangabeys, and this sequence was used for designing species-specific primers.
For full-length sequencing and functional analysis, CCR5 amplicons were cloned into the mammalian expression vector pcDNA3 (Invitrogen) with the signal sequence FLAG epitope (DYKDDDDK) fused to the amino terminus. CCR5 sequences were PCR-amplified using primers (forward) 5′-TCGACTCGAGGATTATCAAGTGTCAAGT-3′ and (reverse) 5′-TCGATCTAGATTAGCTGGAGTGAAAACT-3′, where the forward primer overlaps the first 18 bp of the ORF while deleting the start methionine codon, and the reverse primer overlaps the last 16 bp of the ORF (XbaI and XhoI sites are underlined). PCR and cycling conditions were as described above except that a lower dNTP concentration (0.1 mM) and a lower cycle number (35) were used to increase the fidelity of the PCR.
Cloning of FLAG-tagged sooty mangabey CCR5 sequences was achieved by trimolecular ligation of gel-purified PCR products digested with XhoI and XbaI, a FLAG sequence released from pBlueScript SK Prol/Flag with HindIII and XhoI, and pcDNA3 digested with HindIII and XbaI. Colonies were screened by colony PCR for proper insert length and orientation. Rhesus macaque CCR5 was cloned in an analogous manner, and the sequence obtained agreed with the published sequence. All constructs used were sequenced on both strands to confirm inserts and allelic differences. Allele sequences were confirmed by comparison of at least three sequences of each allele that were independently amplified and cloned from at least three sooty mangabeys. FLAG-tagged huCCR5 was previously described.
CCR5 genotyping of sooty mangabeys
A PCR-based genotyping assay was adapted from a previously reported method for identification of CCR5∆32 alleles in human genomic DNA. PCR was performed on genomic DNA extracts prepared as described above. Genomic DNA (0.3-0.6 µg) was amplified using 5′-TGTTTGCTTTAAAAGCCAGGACAGTCACCTTTGG-3′ and 5′-GAGTGGGTCACCGGIACACTTGAGTCCAGGTCA-3′ as forward and reverse primers, respectively. PCR mixtures contained 5% DMSO, MgCl 2 (1.5 mM), primers (0.5 µM each), dNTPs (0.2 µM each) and Taq polymerase (0.6 U) in Perkin Elmer Buffer II (Perkin Elmer) in a reaction volume of 12 µl. Plasmid DNAs (35 pg) were used as controls in each PCR to simulate amplification of homozygotes (single plasmids) and heterozygotes (both plasmids). Cycling conditions were as follows: one denaturation step at 94°C, followed by 35 cycles of 1 min at 93°C, 1 min at 60°C, 1 min at 72°C, followed by a final extention step of 10 min at 72°C. The 689 bp PCR product (5 µl) was digested with 5U EcoRI for 1 h at 37°C, and the cleaved products electrophoresed in a 3% NuSieve agarose gel (FMC), stained with ethidium bromide, and visualized with ultraviolet light.
Transient expression studies and infection assay
COS-7 cells were maintained in Iscoves medium containing 10% FBS with antibiotics. Cells were plated overnight in 6-well plates at 3 × 10 5 cells per well in 2 ml DMEM with 10% FBS with antibiotics. After 24 h, monolayers were cotransfected with pcDNA3 vector alone, human CD4 0.5 µg alone, or human CD4 0.5 µg with 1 µg of either huCCR5, rhCCR5, smCCR5, smCCR5∆24, or pcDNA3 vector using the Lipofectamine method (Life Technologies). After 24 h, cells were harvested and receptor expression was measured by multiparameter flow cytometry. CD4 expression was detected using a FITC-conjugated anti-CD4 monoclonal antibody (Becton Dickinson), and chemokine receptor expression by staining with phycoerythrin (PE)-conjugated M2 anti-FLAG antibody (Kodak). Surface expression was characterized by staining live cells that excluded propidium iodide. Intracellular expression was detected by using the Fix and Perm Kit (Caltag) on replicate transfected wells. Surface and intracellular expression staining was done in parallel and in triplicate. Vector-transfected monolayers were stained and used as negative controls for flow cytometry analysis.
A low passage stock of SIVmac239 was amplified on CEM × 174 cells. For infection assays, COS-7 cells were transfected as described above and then infected with 32,000 TCID 50 (~250 ng p27) of SIVmac239 on the following day. Inoculum was replaced the next day. After 72 h, SIV-infected monolayers were harvested, fixed and permeabilized, and stained for CD4 and SIV gag p27 core antigen with an anti-p27 mouse monoclonal antibody (Fitzgerald Industries), a FITCconjugated goat anti-mouse antibody (Becton Dickinson), and finally with a PE-conjugated anti-CD4 antibody. Cells positive for p27 were assayed after gating on transfected (CD4 + ) cells. Infections were performed in triplicate.
Flow cytometry analysis of activated peripheral blood lymphocytes
PE-conjugated 3A9 antibody (LeukoSite) was found to cross-react with sooty mangabey CCR5 and was used for in vivo expression studies. PBMC were cultured from six smCCR5/smCCR5∆24 heterozygous animals and from six smCCR5/smCCR5 homozygous animals as determined by PCR genotyping. Within each genotype, three animals were HIV-2 seronegative and three were seropositive. PBMCs were activated with anti-simian-CD3 antibodies (BioSource), and recombinant human interleukin-2 (100 U/ml) (Chiron) was added to the culture 2 days after activation. Lymphocytes were identified using multiparameter flow cytometry by forward and side-scatter characteristics and were assayed for expression of CCR5 by staining with 3A9 PE-conjugated antibody on day 7 after activation. An irrelevant PE-conjugated IgG2α antibody was used to detect nonspecific binding and did not stain significantly. Propidium iodide was used to exclude dead cells.
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